Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,001 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma

NCT01836484

Conditions
Cervical Cancer: Invasive Disease, FIGO Stage 1B1 or Higher, Disease, Endometrial Cancer, +29 more
Locations
  • Queen Elizabeth Hospital, Birmingham University Hospitals, Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • Birmingham City Hospital, Sandwell & West Birmingham Hospitals NHS Trust Birmingham, United Kingdom
  • St Bartholomew's Hospital, Barts Health NHS Trust London, United Kingdom
  • University College London Hospital London, United Kingdom
View Trial Details
Completed

A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma

NCT00426764

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Moore UCSD Cancer Center La Jolla, California, United States
  • UCLA Division of Hematology Oncology Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Rocky Mountain Cancer Centers-Aurora Aurora, Colorado, United States
View all 90 locations
View Trial Details
Completed

A Study of Obinutuzumab + Bendamustine (BG) in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL)

NCT02320487

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Southern Cancer Center - Mobile Mobile, Alabama, United States
  • Ironwood Cancer TX & Rsch Ctrs Chandler, Arizona, United States
  • Arizona Oncology Associates, PC - HAL Tempe, Arizona, United States
View all 26 locations
View Trial Details
Completed

Bendamustine Hydrochloride, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma

NCT01049945

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • City of Hope Duarte, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)

NCT01207388

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations
  • 1102 - LKH Graz Graz, Austria
  • 1107 - Krankenhaus der Elisabethinen Linz, Austria
  • 1106 Salzburg, Austria
  • 1101 - AKH Wien Vienna, Austria
View all 75 locations
View Trial Details
Completed

A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) [The RETRO Study]

NCT02377947

Conditions
Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +18 more
Locations
  • Medanta Hospital Gurgaon, India
  • Research facility ORG-000333 Gurgaon, India
  • Sir Ganga Ram Hospital New Delhi, India
View Trial Details

Related conditions